JP2023554347A5 - - Google Patents
Info
- Publication number
- JP2023554347A5 JP2023554347A5 JP2023536045A JP2023536045A JP2023554347A5 JP 2023554347 A5 JP2023554347 A5 JP 2023554347A5 JP 2023536045 A JP2023536045 A JP 2023536045A JP 2023536045 A JP2023536045 A JP 2023536045A JP 2023554347 A5 JP2023554347 A5 JP 2023554347A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- chain variable
- variable region
- factor
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063127536P | 2020-12-18 | 2020-12-18 | |
| US63/127,536 | 2020-12-18 | ||
| PCT/US2021/064117 WO2022133263A1 (en) | 2020-12-18 | 2021-12-17 | Methods for the detection of anti-drug antibodies against factor xi and/or factor xia antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023554347A JP2023554347A (ja) | 2023-12-27 |
| JP2023554347A5 true JP2023554347A5 (https=) | 2024-12-23 |
Family
ID=82059801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023536045A Pending JP2023554347A (ja) | 2020-12-18 | 2021-12-17 | 第ＸＩ因子および／または第ＸＩａ因子抗体に対する抗薬物抗体を検出するための方法 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20240077497A1 (https=) |
| EP (1) | EP4264278A4 (https=) |
| JP (1) | JP2023554347A (https=) |
| KR (1) | KR20230121120A (https=) |
| CN (1) | CN116601491A (https=) |
| AR (1) | AR124434A1 (https=) |
| AU (1) | AU2021401421A1 (https=) |
| CA (1) | CA3199482A1 (https=) |
| CL (1) | CL2023001709A1 (https=) |
| CO (1) | CO2023008150A2 (https=) |
| CR (1) | CR20230313A (https=) |
| CU (1) | CU20230031A7 (https=) |
| EC (1) | ECSP23053645A (https=) |
| IL (1) | IL302904A (https=) |
| JO (1) | JOP20230137A1 (https=) |
| MX (1) | MX2023007281A (https=) |
| PE (1) | PE20231679A1 (https=) |
| TW (1) | TW202242414A (https=) |
| WO (1) | WO2022133263A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025523802A (ja) * | 2022-07-13 | 2025-07-25 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 分析物を検出するための弱酸性免疫アッセイ |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY36751A (es) * | 2015-06-26 | 2017-01-31 | Novartis Ag | Anticuerpos de factor xi y métodos de uso |
| EP3713965A1 (en) * | 2017-11-22 | 2020-09-30 | Novartis AG | Reversal binding agents for anti-factor xi/xia antibodies and uses thereof |
| MX2020004921A (es) * | 2017-11-29 | 2020-08-27 | Hoffmann La Roche | Ensayo de anticuerpo antifarmaco con supresion de interferencia del objetivo. |
| WO2020231992A1 (en) * | 2019-05-13 | 2020-11-19 | Regeneron Pharmaceuticals, Inc. | Improved competitive ligand binding assays |
-
2021
- 2021-12-17 CA CA3199482A patent/CA3199482A1/en active Pending
- 2021-12-17 PE PE2023001878A patent/PE20231679A1/es unknown
- 2021-12-17 IL IL302904A patent/IL302904A/en unknown
- 2021-12-17 WO PCT/US2021/064117 patent/WO2022133263A1/en not_active Ceased
- 2021-12-17 EP EP21907922.5A patent/EP4264278A4/en active Pending
- 2021-12-17 AU AU2021401421A patent/AU2021401421A1/en active Pending
- 2021-12-17 CU CU2023000031A patent/CU20230031A7/es unknown
- 2021-12-17 JP JP2023536045A patent/JP2023554347A/ja active Pending
- 2021-12-17 MX MX2023007281A patent/MX2023007281A/es unknown
- 2021-12-17 KR KR1020237023913A patent/KR20230121120A/ko active Pending
- 2021-12-17 CR CR20230313A patent/CR20230313A/es unknown
- 2021-12-17 CN CN202180084721.3A patent/CN116601491A/zh active Pending
- 2021-12-20 TW TW110147788A patent/TW202242414A/zh unknown
- 2021-12-20 AR ARP210103581A patent/AR124434A1/es unknown
-
2023
- 2023-06-13 CL CL2023001709A patent/CL2023001709A1/es unknown
- 2023-06-14 JO JOJO/P/2023/0137A patent/JOP20230137A1/ar unknown
- 2023-06-15 US US18/335,507 patent/US20240077497A1/en active Pending
- 2023-06-22 CO CONC2023/0008150A patent/CO2023008150A2/es unknown
- 2023-07-17 EC ECSENADI202353645A patent/ECSP23053645A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112574307B (zh) | 抗人Claudin18.2抗体及其应用 | |
| US20200347130A1 (en) | CD96 Antibody, Antigen-Binding Fragment and Pharmaceutical use Thereof | |
| JP7649744B2 (ja) | Ｂｔｎ３ａ結合タンパク質及びその使用 | |
| CN103483450B (zh) | 抗人cxcl1单克隆抗体或其片段 | |
| CN112409488B (zh) | 针对多种冠状病毒的单克隆抗体及应用 | |
| CN111454359B (zh) | Cd47抗体或其免疫活性片段及应用 | |
| JP2022526528A (ja) | ピログルタメートアミロイド－βに対する抗体及びその使用 | |
| RU2010117018A (ru) | Антитела к gdf8 и их применения | |
| JP2025506172A5 (https=) | ||
| KR20180128436A (ko) | 인자 xi의 활성 부위에 대한 모노클로날 항체 및 이의 용도 | |
| IL314799A (en) | Human monoclonal antibodies that broadly target coronaviruses | |
| TW202300526A (zh) | 針對ｇｄｆ－１５的抗體 | |
| CN109721656B (zh) | 靶向rankl的治疗性抗体 | |
| CN105745225A (zh) | Nav1.7抗体和使用所述抗体的方法 | |
| AU2024201503A1 (en) | Clinical assessment of M-protein response in multiple myeloma | |
| JP2025505650A5 (https=) | ||
| KR102373502B1 (ko) | 골수유래억제세포 관련 질환의 예방 및 치료 용도 | |
| JP2023554347A5 (https=) | ||
| CN114578066B (zh) | 检测β-淀粉样蛋白的产品和方法 | |
| CN114594272B (zh) | 用于检测β-淀粉样蛋白的产品和方法 | |
| CN112521493B (zh) | 抗口蹄疫o型病毒单克隆抗体及其应用 | |
| JP5683466B2 (ja) | 抗ｐｓｋ抗体 | |
| TW202328207A (zh) | 減少血清學測定中抗CD38 mAb藥物干擾的方法 | |
| JP2024502670A5 (https=) | ||
| KR20220092744A (ko) | 말 인플루엔자 바이러스 h3n8형에 특이적인 단일클론항체 및 이를 이용한 말인플루엔자 바이러스 검출용 조성물 |